Subsidiary7 Sept 2026, 08:40 pm
Alembic Pharma Incorporates Wholly Owned Subsidiary in UAE
AI Summary
Alembic Pharmaceuticals Ltd has announced the incorporation of its wholly owned subsidiary, Alembic Pharmaceuticals Global FZCO, in Dubai, United Arab Emirates. The subsidiary was incorporated on August 24, 2026, with an initial investment of AED 100,000. Its primary objective is to explore new business opportunities and promote, sell, and distribute the company's pharmaceutical products in the region. This move signifies Alembic Pharma's strategic expansion into international markets to enhance its global presence and sales network.
Key Highlights
- Alembic Pharmaceuticals established a new wholly owned subsidiary in UAE.
- The subsidiary, Alembic Pharmaceuticals Global FZCO, aims to boost international sales.
- Initial investment in the subsidiary is AED 100,000.
- The company seeks to expand its global reach and product distribution.
Price Impact
More from APLLTD